Bioassay of ethyl tellurac for possible carcinogenicity / Carcinogenesis Testing Program, Division of Cancer Cause and Prevention, National Cancer Institute, National Institutes of Health.

Format Electronic
Publication InfoBethesda, Md. : U.S. Dept. of Health, Education, and Welfare, Public Health Service, National Institutes of Health, 1979.
Description1 online resource (ix, 112 pages) : illustrations.
Supplemental Contenthttps://purl.fdlp.gov/GPO/gpo36243
Subjects

Other author/creatorNational Cancer Institute (U.S.). Division of Cancer Cause and Prevention.
Other author/creatorFrederick Cancer Research Center.
Other author/creatorCarcinogenesis Testing Program (U.S.)
Other author/creatorNational Institutes of Health (U.S.)
SeriesCarcinogenesis technical report series ; no. 152
DHEW publication ; no. (NIH) 79-1708
National Cancer Institute carcinogenesis technical report series ; no. 152. ^A1107162
DHEW publication no. (NIH) 79-1708. ^A204
General noteTitle from title screen (viewed on June 4, 2013).
General note"This bioassay of ethyl tellurac was conducted by the NCI Frederick Cancer Research Center (FCRC)."
General note"CAS no. 20941-65-5 and 30145-38-1."
General note"NCI-CG-TR-152."
Bibliography noteIncludes bibliographical references (p. 39-40).
Issued in other formPrint version: National Cancer Institute (U.S.). Division of Cancer Cause and Prevention. Bioassay of ethyl tellurac for possible carcinogenicity
Technical rpt#CAS no. 20941-65-5
Technical rpt#CAS no. 30145-38-1
GPO item number0507-G-12 (online)
Govt. docs number HE 20.3159/2:152

Availability

Library Location Call Number Status Item Actions
Electronic Resources Access Content Online ✔ Available